Search results for “Meibomian gland dysfunction” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 484 patents, we discovered top 57 key players by total patent application. Azura Ophthalmics Ltd., TearScience, Inc., Novaliq GmbH are dominant in this area. They take 34.50% of the total patent filing.
STARTUP
Azura Ophthalmics Ltd.
Israel
Patent: 89
TearScience, Inc.
North Carolina, United States
Patent: 42
Novaliq GmbH
Baden-Württemberg, Germany
Patent: 36
Santen Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 33
Novartis AG
Basel-Stadt, Switzerland
Patent: 25
Senju Pharmaceutical Beijing Co. Ltd.
Beijing Shi, China
Patent: 23
Senju-USA, Inc.
California, United States
Patent: 13
Nippon Chemiphar Co., Ltd.
Tokyo-to, Japan
Patent: 11
Ocugen, Inc.
Pennsylvania, United States
Patent: 10
The Board of Trustees of the University of Illinois
Illinois, United States
Patent: 10
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 91 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Azura Ophthalmics Ltd.
Israel
Patent: 89
STARTUP
Cloudbreak Therapeutics LLC
California, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 238 patents applied in the last 5 years. We discover 54 most active companies in this area. The fast-growing Azura Ophthalmics Ltd., Novartis AG, Duke University take 36.55% of patent filing during this period.
STARTUP
Azura Ophthalmics Ltd.
Israel
Patent: 51
Novartis AG
Basel-Stadt, Switzerland
Patent: 25
Duke University
North Carolina, United States
Patent: 11
ADS Therapeutics LLC
United States
Patent: 9
OCuSoFT, Inc.
Texas, United States
Patent: 8
Novaliq GmbH
Baden-Württemberg, Germany
Patent: 8
The Schepens Eye Research Institute, Inc.
Massachusetts, United States
Patent: 7
Medic (Tianjin) limited liability company
Tianjin Shi, China
Patent: 6
Hovione Scientia Ltd.
Ireland
Patent: 5
Santen Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 238 patents in last 5 years, we discover 41 new entrants. Novartis AG, Duke University, ADS Therapeutics LLC are the most active new entrants in this area.
Novartis AG
Basel-Stadt, Switzerland
Patent: 25
Duke University
North Carolina, United States
Patent: 11
ADS Therapeutics LLC
United States
Patent: 9
Medic (Tianjin) limited liability company
Tianjin Shi, China
Patent: 6
Hovione Scientia Ltd.
Ireland
Patent: 5
Altaire Pharmaceuticals, Inc.
New York, United States
Patent: 3
The Fourth Affiliated Hospital of China Medical University
undefined undefined
Patent: 2
H4 Orphan Pharma SAS
France
Patent: 2
STARTUP
Cloudbreak Therapeutics LLC
California, United States
Patent: 2
Yonsei Industry-Academic Cooperation Foundation
South Korea
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 57 patents, we discovered top 10 universities and scientific research institutions by total patent application. Duke University, Keio University, Xiamen University are dominant in this area. They take 56.14% of the total patent filing.
Duke University
North Carolina, United States
Patent: 11
Keio University
Tokyo-to, Japan
Patent: 4
Xiamen University
Fujian Sheng, China
Patent: 2
National University of Singapore
Central Region, Singapore
Patent: 1
Nanyang Technological University
Central Region, Singapore
Patent: 1
Tongji University
Shanghai Shi, China
Patent: 1
University of Copenhagen
Hovedstaden, Denmark
Patent: 1
University of Helsinki
Finland
Patent: 1
Taiyuan University of Technology
Shanxi Sheng, China
Patent: 1
The New England College of Optometry
Massachusetts, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: